Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Pure Autonomic Failure
- Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
- Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
- [18F]F-DOPA Imaging in Patients With Autonomic Failure
- Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
- Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
- Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
- Clinical Laboratory Evaluation of Chronic Autonomic Failure
- Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
- Automated Abdominal Binder for Orthostatic Hypotension
- Treatment of Supine Hypertension in Autonomic Failure (CPAP)
- Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- Norepinephrine Transporter Blockade, Autonomic Failure
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)
- TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
- Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure
- Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- Water and Sudafed in Autonomic Failure
- A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)
- Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
- Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)
- The Role of Endothelin in the Supine Hypertension of Autonomic Failure
- Nebivolol in the Supine Hypertension of Autonomic Failure
- A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa
- Mechanisms of Hypoglycemia Associated Autonomic Failure
- Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
- Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q4
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
- Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q5
- Hypoglycemia Associated Autonomic Failure in Type 1 DM
- Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2
- Treatment of Supine Hypertension in Autonomic Failure
- Treatment of Orthostatic Hypotension in Autonomic Failure
- The Autonomic Nervous System and Obesity
- Nitric Oxide and the Autonomic Nervous System